Skip to main content

Enter a phrase above to search within the site.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Webinar: Women, Pregnancy and Addiction: Understanding and Addressing Stigma Amongst Healthcare Providers and the General Public
The: Interagency Work Group on Drinking and Drug Use in Women and Girls will sponsor the following webinar: Women, Pregnancy and Addiction: Understanding and Addressing Stigma Amongst Healthcare Providers and the General Public Friday, November 22, 2019 11:00 am – 12:00 pm EST Join WebEx Meeting: https://nih.webex.com/nih Call-in toll number (US/Canada) 1-650-479-3208 Meeting Number (access code) 628-471-581 Meeting Password: NIAAA...
Joint Meeting Agenda for December 13, 2012
The National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board Joint Meeting Thursday, December 13, 2012 11:30 am to 1:00 pm ET 1-888-324-8014 (toll-free); Passcode is 4418818 Agenda 11:30 am Call to Order Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH Review of Policy and Procedures Justin...
In Memoriam: Dr. Daniel W. Hommer, M.D.

Dr. Daniel W. Hommer, M.D., beloved and respected member of the NIAAA research community, served as Chief of the Section of Brain Electrophysiology and Imaging from 1992 until 2012. There Dan led a team of talented researchers who performed groundbreaking work on the structural and functional effects of alcohol on the brain. Dan, a Fellow of the American College of...

Register for the FDA, NIAAA, AASLD Workshop: Clinical Trial Design and Endpoints for Alcoholic Hepatitis and other Alcohol-Associated Liver Diseases, March 26-27
The purpose of this workshop is to address challenges related to clinical trial designs and drug development in Alcoholic Associated Liver Disease (AALD) and Alcoholic Hepatitis (AH) including populations to study, endpoints, and diagnostic criteria. For additional details visit https://niaaa.nih.gov/alcoholic-hepatitis-workshop-fda-niaaa-aasld Link for watching the workshop remotely: https://collaboration.fda.gov/greatv/ Date: March 26-27, 2018 Location: Food and Drug Administration Great Room – White...
Contact Us

Public Inquiries - Ask NIAAA The information and email services on this website cannot provide personalized medical advice about conditions or treatments. The information and resources on this site or provided through Ask NIAAA should not be used as a substitute for professional medical care. Consult your medical care provider for answers to personal health questions. For questions about NIAAA...

NIH HEAL Initiative Concept: Developing an Evidence Base for OUD-AUD Interventions
Mark Egli, Ph.D. May 09, 2023 Background At least 30% of people with OUD also have AUD. Research projects dedicated to OUD treatment and prevention do not exclude subjects who drink, but seldom explicitly recruit subjects with AUD. Reciprocal relationships between opioid use and alcohol use sometimes seen in treatment contexts such that reduced opioid misuse and opioid agonist therapy...
Surveillance Report COVID-19
Alcohol Sales During the COVID-19 Pandemic Here we present such data as are available on per capita alcohol sales during the COVID-19 pandemic. We do so as a service both to the general public and to researchers who are interested in how recent events surrounding the COVID-19 pandemic have affected the nation's alcohol consumption. NIAAA routinely reports apparent per capita...
Table 2. Number and rate of discharges with any (all-listed) mention of an alcohol-related diagnosis for U.S. population ages 12 and older, by sex and age group, 2000–2015
Diagnostic category and year Number of discharges (in 1,000s) Rate per 10,000 population Total 1 Male Female 12–20 years 21–24 years 25–44 years 45–64 years 65+ years Total 1 Male Female 12–20 years 21–24 years 25–44 years 45–64 years 65+ years Any alcohol-related diagnosis 2015 2576.6 1680.6 895.5 36.3 58.3 573.5 1317.0 591.5 94.64 126.25 64.36 9.60 31.78 67.88 156.98...
Table 1. Number and rate of discharges with principal (first-listed) mention of an alcohol-related diagnosis for U.S. population ages 12 and older, by sex and age group, 2000–2015
Diagnostic category and year Number of discharges (in 1,000s) Rate per 10,000 population Total 1 Male Female 12–20 years 21–24 years 25–44 years 45–64 years 65+ years Total 1 Male Female 12–20 years 21–24 years 25–44 years 45–64 years 65+ years Any alcohol-related diagnosis 2015 411.7 289.0 122.6 3.0 7.0 123.7 228.5 49.5 15.12 21.71 8.81 0.80 3.79 14.65 27.24...
Martha (Sonsy) Fermin, HRSA
Martha (Sonsy) Fermin, MSW, LICSW Senior Public Health Analyst Division of Healthy Start and Perinatal Services Maternal and Child Health Bureau Health Resources and Services Administration (HRSA) 5600 Fishers Lane Rockville, MD 20857 Office: (301) 443-1504 Email:mfermin@hrsa.gov Biographical Summary CAPT Martha (Sonsy) Fermín, a Licensed Clinical Social Worker, currently serves as a Senior Public Health Analyst in the Maternal and...
New Funding Opportunity: Dynamic Neuroimmune Interactions in the Transition from Brain Function to Dysfunction, RFA-AA-18-007

NIAAA has issued the following RFA for the NIH Blueprint for Neuroscience Research Dynamic Neuroimmune Interactions in the Transition from Brain Function to Dysfunction RFA-AA-18-007, R01 https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-18-007.html The goal of this NOFO is to transform our understanding of how dynamic interactions among multiple cell types involved in neuroimmune interactions (e.g., neurons, glia cells, neurovascular units, or other neuroimmune components) mediate...

ABCD study completes enrollment, announces opportunities for scientific engagement

The National Institutes of Health announced today that enrollment for the Adolescent Brain Cognitive Development (ABCD) Study is now complete and, in early 2019, scientists will have access to baseline data from all ABCD Study participants. There are 11,874 youth, ages 9-10, participating in the study, including 2,100 young people who are twins or triplets. All will be followed through...

Pharmacotherapy Webinar featuring Dr. Sandra Springer, Yale AIDS Program
NEW LOCATION: Zoom Platform Webinar Title: Pharmacotherapy of Addiction Integrated with HIV Treatment Upon Reentry into the Community from Prison Improves Outcomes Speaker: Sandra Springer, MD, Associate Professor of Medicine, Yale School of Medicine, Section of Infectious Disease, Yale AIDS Program, VA Connecticut Healthcare System Access the Zoom link here: https://bit.ly/ReturningCitizens2 Meeting number/Access Code: 126 600 0267 Password: FridayNov20 Join...

Virtual Roundtable Discussion with Dr. Koob
Tune in for the NIAAA Liaison Group Virtual Roundtable Discussion with NIAAA Director Dr. George F. Koob and the NIAAA senior staff. When: September 13, 2022 at 12 noon ET The roundtable will include: • An update from NIAAA Director Dr. George F. Koob • A short presentation about the Healthcare Professional's Core Resource on Alcohol from Dr. Laura Kwako...
Table 13
Table 13. Alcohol involvement 1 among young drivers under age 21 and drivers ages 21 and older in fatal traffic crashes, United States, 1982–2004. Year Drivers 2 Under age 21 Ages 21 and older Total Alcohol-involved Total Alcohol-involved Number Percent Number Percent 2004 8,100 1,820 22.5 49,397 12,269 24.8 2003 8,089 1,876 23.2 49,541 12,230 24.7 2002 8,463 1,931 22.8...
Table 8
Table 8. Drivers involved in fatal traffic crashes and given blood alcohol concentration (BAC) tests, according to injury severity, United States, 1982–2004. Year Drivers given BAC tests Dead Alive All Number Percent Number Percent Number Percent 2004 19,969 74.3 9,637 31.2 29,638 50.8 2003 20,138 75.2 9,354 30.0 29,517 50.4 2002 20,163 75.6 9,733 31.5 29,916 51.5 2001 19,814 76.6...
CRAN Will Host a Pre-Application Technical Assistance Webinar for the ABCD Study
This is a correction to the webex connection information for the ABCD pre-application technical assistance webinar, which will be conducted on Tuesday, February 24, 2015 from 1:00 to 2:30 p.m. EST to discuss the three new Adolescent Brain Cognitive Development (ABCD) Longitudinal Study funding opportunities: (1) a set of research project sites ( RFA-DA-15-015), (2) a single central data analysis...
Risk-Based Monitoring and Reporting Requirements for NIAAA Funded Clinical Trials
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) requires enhanced monitoring and reporting for NIAAA-supported clinical trials that are rated as greater than minimal risk (as defined in federal regulations at 45 CFR 46.102(i) and 21 CFR 50.3(k)). The purpose of this guidance document is to clarify risk level definitions and NIAAA’s monitoring and reporting expectations for all NIAAA-funded...
Laboratory of Liver Diseases

Mission Statement: The mission of the Laboratory of Liver Diseases is to investigate the immunological aspects and molecular pathogenesis of alcoholic and nonalcoholic fatty liver diseases, and to explore novel therapeutic targets for the treatment of these disorders. Bin Gao MD. , PhD, Chief Laboratory of Liver Diseases National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625...

Frontiers in Addiction Research Mini-Convention - "Relapse and Recovery: from Mechanistic Understanding to Translational Research"
November 11, 2016, 8:30am - 5:30pm San Diego Convention Center, Room 7; San Diego, California Visit the Web site Summary The theme of this year’s mini-convention is on relapse and recovery, with an emphasis on integration of preclinical and clinical research and leveraging insights from big data approaches. The symposium will highlight notable studies in drug and alcohol research, in...
Looking for U.S. government information and services?
Visit USA.gov